Showing results (51-60 of 85) with videos related to

Sort By:
Pageof 9
Stem Cells Translational Medicine|February 11, 2017
Mesenchymal Stromal Cell Therapy for Chronic Lung Allograft Dysfunction: Results of a First-in-Man StudyDaniel C Chambers, Debra Enever, Sharon Lawrence, et al.
The Lancet. Oncology|November 17, 2012
Tolerability, safety, pharmacokinetics, and efficacy of doxorubicin-loaded anti-EGFR immunoliposomes in advanced solid tumours: a phase 1 dose-escalation studyChristoph Mamot, Reto Ritschard, Andreas Wicki, et al.
European Journal of Cancer (Oxford, England : 1990)|September 9, 2010
Diagnostic and prognostic role of plasma levels of two forms of cytokeratin 18 in patients with non-small-cell lung cancerLuigi De Petris, Eva Brandén, Richard Herrmann, et al.
Blood|April 20, 2002
High frequency of point mutations clustered within the adenosine triphosphate-binding region of BCR/ABL in patients with chronic myeloid leukemia or Ph-positive acute lymphoblastic leukemia who develop imatinib (STI571) resistanceSusan Branford, Zbigniew Rudzki, Sonya Walsh, et al.
BMC Cancer|July 12, 2008
A single dose of pegfilgrastim compared with daily filgrastim for supporting neutrophil recovery in patients treated for low-to-intermediate risk acute myeloid leukemia: results from a randomized, double-blind, phase 2 trialJorge Sierra, Jeffrey Szer, Jeannine Kassis, et al.
Leukemia & Lymphoma|May 9, 2008
A phase II study of liposomal daunorubicin, in combination with cyclophosphamide, vincristine and prednisolone, in elderly patients with previously untreated aggressive non-Hodgkin lymphomaPaul L R Mitchell, Paula Marlton, Andrew Grigg, et al.
Comptes Rendus Biologies|February 5, 2008
Death toll exceeded 70,000 in Europe during the summer of 2003Jean-Marie Robine, Siu Lan K Cheung, Sophie Le Roy, et al.
Acta Oncologica (Stockholm, Sweden)|December 28, 2010
A phase I study of the oral platinum agent satraplatin in sequential combination with capecitabine in the treatment of patients with advanced solid malignanciesElisa Gallerani, Jean Bauer, Dagmar Hess, et al.
The Lancet. Oncology|February 6, 2008
CA 19-9 tumour-marker response to chemotherapy in patients with advanced pancreatic cancer enrolled in a randomised controlled trialViviane Hess, Bengt Glimelius, Philipp Grawe, et al.
The Journal of Gene Medicine|August 5, 2003
Phase I immunotherapy with a modified vaccinia virus (MVA) expressing human MUC1 as antigen-specific immunotherapy in patients with MUC1-positive advanced cancerChristoph Rochlitz, Robert Figlin, Patrick Squiban, et al.
Pageof 9